Cervical cancer screening in low- and middle-income countries: A systematic review of economic evaluation studies
Authors:
- Carmen Phang Romero CasasCCCarmen Phang Romero Casas
- Rita de Cássia Ribeiro de AlbuquerqueRARita de Cássia Ribeiro de Albuquerque
- Rafaela Borge LoureiroRLRafaela Borge Loureiro
- Angela Maria GollnerAGAngela Maria Gollner
- Marina Gonçalves de FreitasMFMarina Gonçalves de Freitas
- Graciela Paula Do Nascimento DuqueGDGraciela Paula Do Nascimento Duque
- Juliana Yukari Kodaira ViscondiJVJuliana Yukari Kodaira Viscondi
Open Access
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Upgrading Public Health Programs for Human Papillomavirus Prevention and Control is Possible in Low- and Middle-income CountriesVaccine, 2012
- Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical CancerVaccine, 2012
- Calibrating Models in Economic EvaluationPharmacoEconomics, 2011
- HPV testing for cervical cancer screening appears more cost-effective than Papanicolau cytology in MexicoCancer Causes & Control, 2010
- Cost‐effectiveness analysis of cervical cancer prevention based on a rapid human papillomavirus screening test in a high‐risk region of ChinaInternational Journal of Cancer, 2010
- Screening, prevention and treatment of cervical cancer—A global and regional generalized cost-effectiveness analysisVaccine, 2009
- Calibration Methods Used in Cancer Simulation Models and Suggested Reporting GuidelinesPharmacoEconomics, 2009
- Coverage of Cervical Cancer Screening in 57 Countries: Low Average Levels and Large InequalitiesPLOS Medicine, 2008
- Relación costo-efectividad de las intervenciones preventivas contra el cáncer cervical en mujeres mexicanasSalud Pública de México, 2008
- Custo-efetividade no diagnóstico precoce do câncer de colo uterino no BrasilPhysis: Revista de Saúde Coletiva, 2006